日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mucosal barrier injury as an independent risk factor for laboratory-confirmed bloodstream infection in patients with hematological malignancies: a real-world study

黏膜屏障损伤是血液系统恶性肿瘤患者实验室确诊血流感染的独立危险因素:一项真实世界研究

Liu, Mengna; Jiang, Xi; Pi, Yingqi; Chen, Mingming; Ren, Xiuqin; Dai, Xinlu; Wu, Yixian; Guo, Yanrong; Zhang, Xinyi; Xie, Xiaoying; Luo, Zhaofan

Serum Osteopontin Enhances Hepatocellular Carcinoma Diagnosis and Predicts Anti-PD-L1 Immunotherapy Benefit.

血清骨桥蛋白可提高肝细胞癌的诊断率并预测抗PD-L1免疫疗法的疗效

Wu Miantao, Zou Fei, He Suyin, Pi Yingqi, Song Yiling, Chen Shulin, Li Linfang

Agrobacterium radiobacter Bacteremia in a Gastric Cancer Patient: A Case Report and Literature Review

根癌农杆菌菌血症在胃癌患者中的发生:病例报告及文献综述

Liu, Mengna; Jiang, Xi; Pi, Yingqi; Ren, Xiuqin; Chen, Mingming; Tang, Shihuan; Dai, Xinlu; Wu, Yixian; Guo, Yanrong; Zhang, Xinyi; Luo, Zhaofan; Xie, Xiaoying

Plasma Macrophage Inhibitory Cytokine-1 as a Complement of Epstein-Barr Virus Related Markers in Identifying Nasopharyngeal Carcinoma.

血浆巨噬细胞抑制细胞因子-1作为Epstein-Barr病毒相关标志物的补充,用于识别鼻咽癌

Xing Shan, Li Huilan, Pi Yingqi, Zeng Tao, Huang Qi, Ou Guoping, Xue Ning

Integrated analysis of long non-coding RNAs and mRNA profiles reveals potential sex-dependent biomarkers of bevacizumab/erlotinib response in advanced lung cancer

长链非编码RNA和mRNA谱的综合分析揭示了晚期肺癌中贝伐珠单抗/厄洛替尼疗效的潜在性别依赖性生物标志物

Tu, Chao; Pi, Yingqi; Xing, Shan; Ling, Yang